Musculoskeletal steroid injections in pregnancy: a review

Skeletal Radiol. 2023 Aug;52(8):1465-1473. doi: 10.1007/s00256-023-04320-9. Epub 2023 Mar 14.

Abstract

Pregnant women experience a wide range of musculoskeletal pain disorders, which include general ailments occurring during pregnancy, exacerbation of pre-existing conditions, or pregnancy-specific pain/inflammatory conditions. There are significant concerns and knowledge gaps surrounding the safety, dosage, and potential long-term effects of several drugs used during pregnancy. Our article reviews the use of focal steroid injections during pregnancy. A mixture of case studies, meta-analyses, and randomised controlled trials have shown at least there is no adverse side effect to the mother or baby from maternal use of non-systemic injection during pregnancy and a significant improvement in symptoms of pain or paraesthesia can be achieved in patients that do not respond to more conservative measures. As with all patients, the use of steroid injection should be judged on a case-by-case basis to ensure that it is the most appropriate treatment choice. However, being pregnant should not be considered a contraindication to a single dose of non-systemic steroid administration, as these women can achieve significant symptomatic relief that reduces reliance on systemic medication and can significantly improve their quality of life.

Keywords: Carpal tunnel syndrome in pregnancy; Joint injection in pregnancy; Musculoskeletal pain in pregnancy; Pregnancy; Steroid injection in pregnancy.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Meta-Analysis as Topic
  • Pain*
  • Pregnancy
  • Quality of Life*
  • Randomized Controlled Trials as Topic
  • Steroids

Substances

  • Steroids